Last reviewed · How we verify

gestoden 60 mcg

Hospital Geral de Fortaleza · FDA-approved active Small molecule Quality 0/100

gestoden 60 mcg is a Small molecule drug developed by Hospital Geral de Fortaleza. It is currently FDA-approved. Also known as: oral contraceptives, quality of life, gestodene and ethinyl estradiol.

At a glance

Generic namegestoden 60 mcg
Also known asoral contraceptives, quality of life, gestodene and ethinyl estradiol
SponsorHospital Geral de Fortaleza
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about gestoden 60 mcg

What is gestoden 60 mcg?

gestoden 60 mcg is a Small molecule drug developed by Hospital Geral de Fortaleza.

Who makes gestoden 60 mcg?

gestoden 60 mcg is developed and marketed by Hospital Geral de Fortaleza (see full Hospital Geral de Fortaleza pipeline at /company/hospital-geral-de-fortaleza).

Is gestoden 60 mcg also known as anything else?

gestoden 60 mcg is also known as oral contraceptives, quality of life, gestodene and ethinyl estradiol.

What development phase is gestoden 60 mcg in?

gestoden 60 mcg is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing